Gardiner, B.J., Mahony, A.A., Ellis, A.G., Lawrentschuk, N., Bolton, D.M., Zeglinski, P.T., et al. (2014) Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis? Clinical Infectious Diseases, 58.
https://doi.org/10.1093/cid/cit704

has been cited by the following article:

• TITLE: Pulmonary Fibrosis Due to Nitrofurantoin Therapy: A Case Report

  AUTHORS: Leonidas Grigorakos, Garyphallia Poulakou, Daria Lazarescu, Pavlos Myrianthefs, Nikolaos Markou, Maria Bikou, Adamantia Petineli, Konstantinos Kokkinis

  KEYWORDS: Nitrofurantoin, Lung Toxicity, Fibrosis, Fosfomycin

  JOURNAL NAME: Open Journal of Respiratory Diseases, Vol.7 No.3, August 15, 2017

  ABSTRACT: We report the case of a patient with pulmonary fibrosis, developed as an adverse reaction to nitrofurantoin therapy received for totally 6 months for the prevention of recurrent urinary tract infections. Chest X-ray and CT scan revealed extensive elements of interstitial pulmonary fibrosis. After diagnosis, administration of nitrofurantoin was immediately stopped; and specific prolonged therapy with low-dose corticosteroids per os and inhaled steroids were administered. The patient responded successfully both clinically and biochemically and possible digestive system side effects were prevented through the administration of gastroprotection medication. For the prevention of urinary tract infection, the patient received well tolerated therapy with fosfomycin which was further continued as a prophylactic agent.